Metabolomics Study of Whole-body Vibration on Lipid Metabolism of Skeletal Muscle in Aging Mice

 

 Buy Article Permissions and Reprints

Abstract

Ageing increases the occurrence and development of many diseases. Exercise is believed to be an effective way to improve ageing and skeletal muscle atrophy. However, many elderly people are unable to engage in active exercise. Whole-body vibration is a passive way of moving that is especially suitable for the elderly and people who find it inconvenient to exercise. Metabolomics is the systematic study of metabolic changes in small molecules. In this study, metabolomics studies were performed to investigate the regulatory effect of whole-body vibration on the skeletal muscles of ageing mice. After 12 weeks, we found that whole-body vibration had the most obvious effect on lipid metabolism pathways (such as linoleic acid, α-linolenic acid metabolism, glycerophospholipid metabolism pathways) in skeletal muscle of ageing mice. Through further research we found that whole-body vibration decreased the levels of triglycerides, total cholesterol, low-density lipoprotein cholesterol and very low-density lipoprotein in blood; decreased the lipid deposition in skeletal muscle; decreased the protein expression of monocyte chemoattractant protein-1 and interleukin-6; improved the protein levels of phosphorylated insulin receptor substrate-1, phosphate phosphoinositide 3-kinase and p-AKT; improved the protein levels of klotho; and decreased the protein expression of p53. These findings reveal that whole-body vibration might postpone senility by attenuating lipid deposition and reducing chronic inflammation and the insulin resistance of skeletal muscle.

Publication History

Received: 10 August 2020

Accepted: 09 September 2020

Article published online:
29 October 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Shen D, Li H, Zhou R. et al. Pioglitazone attenuates aging-related disorders in aged apolipoprotein E deficient mice. Exp Gerontol 2018; 102: 101-108
  CrossrefPubMedGoogle Scholar
• 2 Susan W, Nikita L, Satya P. Longevity extension in drosophila through gut-brain communication. Sci Rep 2018; 8: 8362
  CrossrefPubMedGoogle Scholar
• 3 Yuho K, Matthew T, Hood DA. Impact of aging and exercise on mitochondrial quality control in skeletal muscle. Oxid Med Cell Longev 2017; 2017: 3165396
  PubMedGoogle Scholar
• 4 Xiang L, Zhang H, Wei J. et al. Metabolomics studies on db/db, diabetic mice in skeletal muscle reveal effective clearance of overloaded intermediates by exercise. Anal Chim Acta 2018; 1037: 130-139 DOI: 10.1016/j.aca.2017.11.082. Epub 2017 Dec 20.
  CrossrefPubMedGoogle Scholar
• 5 Cha HN, Park S, Dan Y. et al. Peroxiredoxin2 deficiency aggravates aging-induced insulin resistance and declines muscle strength. J Gerontol A Biol Sci Med Sci 2019; 74: 147-154
  CrossrefPubMedGoogle Scholar
• 6 Metwally IEL, Ahmed KA. Royal jelly supplementation reduces skeletal muscle lipotoxicity and insulin resistance in aged obese rats. Pathophysiology 2018; 25: 307-315
  CrossrefPubMedGoogle Scholar
• 7 Kauppila TE, Kauppila JH, Larsson NG. Mammalian mitochondria and aging: an update. Cell Metab 2017; 25: 57-71
  CrossrefPubMedGoogle Scholar
• 8 Heden Timothy D, Johnson Jordan M, Ferrara Patrick J. et al. Mitochondrial PE potentiates respiratory enzymes to amplify skeletal muscle aerobic capacity. Sci Adv 2019; 5: eaax8352
  CrossrefPubMedGoogle Scholar
• 9 Cartee G, Hepple R, Bamman M. et al. Exercise promotes healthy aging of skeletal muscle. Cell Metab 2016; 23: 1034-1047
  CrossrefPubMedGoogle Scholar
• 10 Monleon D, Garcia-Valles R, Morales JM. et al. Metabolomic analysis of long-term spontaneous exercise in mice suggests increased lipolysis and altered glucose metabolism when animals are at rest. J Appl Physiol (1985) 2014; 117: 1110-1119
  CrossrefPubMedGoogle Scholar
• 11 Prior SJ, Goldberg AP, Ortmeyer HK. et al. Increased skeletal muscle capillarization independently enhances insulin sensitivity in older adults after exercise training and detraining. Diabetes 2015; 64: 3386-3395
  CrossrefPubMedGoogle Scholar
• 12 Lewis GD, Farrell L, Wood MJ. et al. Metabolic signatures of exercise in human plasma. Sci Transl Med 2010; 2: 33ra37
  CrossrefPubMedGoogle Scholar
• 13 Carlucci F, Orlando G, Haxhi J. et al. Older age is associated with lower optimal vibration frequency in lower-limb muscles during whole-body vibration. Am J Phys Med Rehabil 2015; 94: 522-529
  CrossrefPubMedGoogle Scholar
• 14 Liu Y, Zhai M, Guo F. et al. Whole-body vibration improves insulin resistance in db/db mice: Amelioration of lipid accumulation and oxidative stress. Appl Biochem Biotech 2016; 179: 819-829
  CrossrefPubMedGoogle Scholar
• 15 Reijne AC, Jolita C, Van DTH. et al. Whole-body vibration partially reverses aging induced increases in visceral adiposity and hepatic lipid storage in mice. PLoS One 2016; 11: e0149419
  CrossrefPubMedGoogle Scholar
• 16 Wu H, Zhang Y, Yang X. et al. Whole body vibration retards progression of atherosclerosis via insulin-like growth factor 1 in apolipoprotein E-deficient mice. Biomed Res Int 2018; 2018: 1-9
  Google Scholar
• 17 Erceg DN, Anderson LJ, Nickles CM. et al. Changes in bone biomarkers, BMC, and insulin resistance following a 10-week whole body vibration exercise program in overweight Latino boys. Int J Med Sci 2015; 12: 494-501
  CrossrefPubMedGoogle Scholar
• 18 Bellia A, Sallì M, Lombardo M. et al. Effects of whole body vibration plus diet on insulin-resistance in middle-aged obese subjects. Int J Sports Med 2013; 35: 511-516
  Article in Thieme ConnectPubMedGoogle Scholar
• 19 Si H, Wang X, Zhang L. et al. Dietary epicatechin improves survival and delays skeletal muscle degeneration in aged mice. FASEB J 2019; 33: 965-977
  CrossrefPubMedGoogle Scholar
• 20 Harriss DJ, Macsween A, Atkinson G. Ethical standards in sport and exercise science research: 2020 update. Int J Sports Med 2019; 40: 813-817
  Article in Thieme ConnectPubMedGoogle Scholar
• 21 Low DY, Sophie Lefèvre-Arbogast, Raúl González-Domínguez. et al. Diet-related metabolites associated with cognitive decline revealed by untargeted metabolomics in a prospective cohort. Mol Nutr Food Res 2019; 63: e1900177
  CrossrefPubMedGoogle Scholar
• 22 Ibero-Baraibar I, Romo-Hualde A, Gonzalez-Navarro CJ. et al. The urinary metabolomics profile following the intake of meals supplemented with a cocoa extract in middle-aged obese subjects. Food Funct 2016; 4: 1924-1931
  CrossrefPubMedGoogle Scholar
• 23 Xiong X, Sheng X, Liu D. et al. A GC/MS-based metabolomics approach for reliable diagnosis of phenylketonuria. Anal Bioanal Chem 2015; 407: 8825-8833
  CrossrefPubMedGoogle Scholar
• 24 Kirac E, Ozcan F, Tuzcu H. et al. Analysis of polyunsaturated fatty acids and theomega-6 inflammatory pathway in hepatic ischemia/re-perfusion injury. Mol Med Rep 2015; 12: 4149-4156
  CrossrefPubMedGoogle Scholar
• 25 Lee SM, An WS. Cardioprotective effects of ω-3 PUFAs in chronic kidney disease. Biomed Res Int 2013; 2013: 712949
  PubMedGoogle Scholar
• 26 Garciacan Averas JC, Donato MT, Castell JV. et al. A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations. J Proteome Res 2011; 10: 4825-4834
  CrossrefPubMedGoogle Scholar
• 27 Swapna K, Sathibabu Uddandrao VV, Parim B. et al. Effects of asiatic acid, an active constituent in Centella asiatica (L.): Restorative perspectives of streptozotocin-nicotinamide induced changes on lipid profile and lipid metabolic enzymes in diabetic rats. Comp Clin Path 2019; 28: 1321-1329
  CrossrefPubMedGoogle Scholar
• 28 Boles U, Pinto RC, David S. et al. Dysregulated fatty acid metabolism in coronary ectasia: An extended lipidomic analysis. Int J Cardiol 2016; 228: 303-308
  CrossrefPubMedGoogle Scholar
• 29 Holmes MV, Millwood IY, Kartsonaki C. et al. Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. J Am Coll Cardiol 2018; 71: 620-632
  CrossrefPubMedGoogle Scholar
• 30 Kim ST, Kyung EJ. et al. Phosphatidylcholine attenuated docetaxel-induced peripheral neurotoxicity in rats. Drug Chem Toxicol 2017; 41: 476-485
  CrossrefPubMedGoogle Scholar
• 31 Cui Y, Liu X, Wang M. et al. Lysophosphatidylcholine and amide as metabolites for detecting Alzheimer disease using ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry-based metabonomics. J Neuropathol Exp Neurol 2014; 73: 954-963
  CrossrefPubMedGoogle Scholar
• 32 Olofsson KE, Andersson L, Nilsson J. et al. Nanomolar concentrations of lysophospha-tidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages. Biochem Biophys Res Commun 2008; 2: 348-352
  CrossrefPubMedGoogle Scholar
• 33 Han M, Lim Y, Quan W. et al. Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. J Lipid Res 2011; 6: 1234-1246
  CrossrefPubMedGoogle Scholar
• 34 Zhang L, Han X, Li Z. et al. Metabolomics research on time-selected combination of Liuwei Dihuang and Jinkui Shenqi pills in treating kidney deficiency and aging by chemometric methods. Chemometr Intell Lab Syst 2014; 130: 50-57
  CrossrefPubMedGoogle Scholar
• 35 Witkowski A, Joshi AK, Smith S. Coupling of the de novo fatty acid biosynthesis and lipoylation pathways in mammalian mitochondria. J Biol Chem 2007; 282: 14178-14185
  CrossrefPubMedGoogle Scholar
• 36 Huang H, Zhang Y, Cao M. et al. Effects of fasting on the activities and mRNA expression levels of lipoprotein lipase (LPL), hor mone-sensitive lipase (HSL) and fatty acid synthetase (FAS) in spotted seabass Lateolabrax maculatus. Fish Physiol Biochem 2018; 44: 387-400
  CrossrefPubMedGoogle Scholar
• 37 Inez T, Amely V, Robert M. et al. Exercise and nutrition strategies to counteract sarcopenic obesity. Nutrients 2018; 10: 605-626
  CrossrefPubMedGoogle Scholar
• 38 Stenholm S, Harris TB, Rantanen T. et al. Sarcopenic obesity: Definition, cause and Consequences. Curr Opin Clin Nutr Metab Care 2008; 11: 693-700
  CrossrefPubMedGoogle Scholar
• 39 Moura SC, Domingues DJM, Ribeiro SGA. et al. Prevalence of obesity, sarcopenic obesity and associated factors: A FIBRA Network study. Fisioter Mov 2017; 30: 161-169
  CrossrefPubMedGoogle Scholar
• 40 Liu C, Zhang C, He T. et al. Study on potential toxic material base and mechanisms of hepatotoxicity induced by Dysosma versipellis based on toxicological evidence chain (TEC) concept. Ecotoxicol Environ Saf 2020; 190: 110073
  CrossrefPubMedGoogle Scholar
• 41 Chung HY, Lee EK, Choi YJ. et al. Molecular inflammation as an underlying mechanism of the aging process and age-related diseases. J Dent Res 2011; 90: 830-840
  CrossrefPubMedGoogle Scholar
• 42 Aoki T, Narumiya S. Prostaglandins and chronic inflammation. Trends Pharmacol Sci 2012; 33: 304-311
  CrossrefPubMedGoogle Scholar
• 43 Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010; 72: 219-246
  CrossrefPubMedGoogle Scholar
• 44 Čejková S, Králová Lesná I, Froněk J. et al. Pro-inflammatory gene expression in adipose tissue of patients with atherosclerosis. Physiol Res 2017; 66: 633-640
  CrossrefPubMedGoogle Scholar
• 45 Kwak HJ, Choi HE, Cheon HG. 5-LO inhibition ameliorates palmitic acid–induced ER stress, oxidative stress and insulin resistance via AMPK activation in murine myotubes. Sci Rep 2017; 7: 017-053
  CrossrefPubMedGoogle Scholar
• 46 Saini V. Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J Diabetes 2010; 1: 68-75
  CrossrefPubMedGoogle Scholar
• 47 Wu C, Xu G, Tsai SA. et al. Transcription profiles of type 2 diabetes in man muscle reveal insulin resistance metabolic defects, apoptosis, and molecular signatures of immune activation in response to infections. Biochem Biophys Res Commun 2017; 482: 282-288
  CrossrefPubMedGoogle Scholar
• 48 Scott D, Cumming R, Naganathan V. et al. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project. Exp Gerontol 2018; 21: 5562-5570
  PubMedGoogle Scholar
• 49 Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev 2017; 35200-35221
  PubMedGoogle Scholar
• 50 Baker LD, Barsness SM, Borson S. et al. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Arch Neurol 2012; 69: 1420-1429
  CrossrefPubMedGoogle Scholar
• 51 Wang H, Hai S, Liu Y. et al. Associations between sarcopenic obesity and cognitive impairment in elderly chinese community-dwelling individuals. J Nutr Health Aging 2019; 23: 14-20
  CrossrefPubMedGoogle Scholar
• 52 Tyrovolas S, Koyanagi A, Olaya B. et al. Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: A multicontinent study. J Cachexia Sarcopenia Muscle 2016; 7: 312-321
  CrossrefPubMedGoogle Scholar
• 53 Aggio D, Sartini C, Papacosta O. et al. Cross-sectional associations of objectively measured physical activity and sedentary time with sarcopenia and sarcopenic obesity in older men. Prev Med 2016; 91: 264-272
  CrossrefPubMedGoogle Scholar
• 54 Leibrock CB, Voelkl J, Kohlhofer U. et al. Bicarbonate sensitive calcification and lifespan of klotho-deficient mice. Am J Physiol Renal Physiol 2016; 91: F102-F108
  CrossrefPubMedGoogle Scholar
• 55 Kuro-o M. Klotho and the aging process. Korean J Intern Med 2011; 26: 113-122
  CrossrefPubMedGoogle Scholar
• 56 Jelena K, Markus G, Tim S. et al. p53 as a dichotomous regulator of liver disease: the dose makes the medicine. Int J Mol Sci 2018; 19: 921
  CrossrefPubMedGoogle Scholar
• 57 Gogna R, Madan E, Kuppusamy P. et al. Re-oxygenation causes hypoxic tumor regression through restoration of p53 wild-type conformation and post-translational modifications. Cell Death Dis 2012; 3: e286
  CrossrefPubMedGoogle Scholar
• 58 Tran D, Bergholz J, Zhang H. et al. Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence. Aging Cell 2014; 13: 669-678
  CrossrefPubMedGoogle Scholar
• 59 Nishizawa H, Iguchi G, Fukuoka H. et al. IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner. Sci Rep 2016; 6: 34605
  Google Scholar
• 60 Fujita K. p53 Isoforms in cellular senescence- and ageing-associated biological and physiological functions. Int J Mol Sci 2019; 20: 6023
  CrossrefPubMedGoogle Scholar
• 61 Wanagat J, Hevener AL. Mitochondrial quality control in insulin resistance and diabetes. Curr Opin Genet Dev 2016; 38: 118-126
  CrossrefPubMedGoogle Scholar